Multimodality instrument for tissue characterization by Andrews, Russell J. & Mah, Robert W.
I Il11 l111111 Ill Il11 Il11 US006718196Bl III 11111 11 11111 11111 11111 1ll I1 1111 Il  
(12) United States Patent (io) Patent No.: US 6,718,196 B1 
Mah et al. (45) Date of Patent: Apr. 6,2004 
MULTIMODALITY INSTRUMENT FOR 
TISSUE CHARACTERIZATION 
Inventors: Robert W. Mah, Cupertino, CA (US); 
Russell J. Andrews, Manilus, NY (US) 
Assignee: The United States of America as 
represented by the National 
Aeronautics and Space 
Administration, Washington, DC (US) 
Subject to any disclaimer, the term of this 
patent is extended or adjusted under 35 
U.S.C. 154(b) by 119 days. 
Notice: 
Appl. No.: 09/652,299 
Filed: Aug. 28, 2000 
Related U.S. Application Data 
Continuation of application No. 091017,519, filed on Feb. 2, 
1998, now Pat. No. 6,109,270, and a continuation of appli- 
cation No. 081795,272, filed on Feb. 4, 1997, now aban- 
doned. 
Int. Cl? .................................................. A61B 6/00 
U.S. C1. ....................... 600/476; 6001117; 6001300; 
6061130; 1281899; 3451156 
Field of Search ................................. 6001473, 478, 
6001476, 466, 464, 435, 434, 342, 407, 
117, 114; 6061300, 2; 1281899, 664 
References Cited 
U.S. PATENT DOCUMENTS 
3,727,613 A * 411973 Sorenson et al. ...... 6041165.02 
4,633,885 A * 111987 DuBrucq et al. 6001549 
4,795,434 A * 111989 Kujawski .................... 6041159 
5,095,910 A * 311992 Powers ......... 
5,304,173 A * 411994 Kittrell et al. 
RE34,663 E * 711994 Seale ......................... 1281774 
5,415,169 A * 511995 Siczek et al. ............... 6001427 
5,438,997 A * 811995 Sieben et al. ............... 6001463 
5,452,716 A * 911995 Clift ........................... 6001373 
5,460,182 A * 1011995 Goodman et al. .......... 6001342 
5,676,145 A * 1011997 Bar-Lavie ................... 6001342 
5,735,276 A * 411998 Lemelson ................... 6001407 
5,850,465 A * 1211998 Shimura et al. ............ 3821132 
5,941,251 A * 811999 Panescu et al. ............. 1281899 
6,109,270 A * 812000 Mah et al. .................. 1281924 
* cited by examiner 
Primary Examinerqeorge Manuel 
Assistant Examineraar ry  Pass 
(74) Attorney, Agent, or FirmDober t  M Padilla; John F. 
Schipper 
(57) ABSTRACT 
A system with multimodality instrument for tissue identifi- 
cation includes a computer-controlled motor driven heuristic 
probe with a multisensory tip. For neurosurgical 
applications, the instrument is mounted on a stereotactic 
frame for the probe to penetrate the brain in a precisely 
controlled fashion. The resistance of the brain tissue being 
penetrated is continually monitored by a miniaturized strain 
gauge attached to the probe tip. Other modality sensors may 
be mounted near the probe tip to provide real-time tissue 
characterizations and the ability to detect the proximity of 
blood vessels, thus eliminating errors normally associated 
with registration of pre-operative scans, tissue swelling, 
elastic tissue deformation, human judgement, etc., and ren- 
dering surgical procedures safer, more accurate, and effi- 
cient. A neural network program adaptively learns the infor- 
mation on resistance and other characteristic features of 
normal brain tissue during the surgery and provides near 
real-time modeling. A fuzzy logic interface to the neural 
network program incorporates expert medical knowledge in 
the learning process. Identification of abnormal brain tissue 
is determined by the detection of change and comparison 
with previously learned models of abnormal brain tissues. 
The operation of the instrument is controlled through a user 
friendly graphical interface. Patient data is presented in a 3D 
stereographics display. Acoustic feedback of selected infor- 
mation may optionally be provided. Upon detection of the 
close proximity to blood vessels or abnormal brain tissue, 
the computer-controlled motor immediately stops probe 
penetration. The use of this system will make surgical 
procedures safer, more accurate, and more efficient. Other 
applications of this system include the detection, prognosis 
and treatment of breast cancer, prostate cancer, spinal 
diseases, and use in general exploratory surgery. 
22 Claims, 7 Drawing Sheets 
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MULTIMODALITY INSTRUMENT FOR 
TISSUE CHARACTERIZATION 
This application is a continuation of application(s) appli- 
cation Ser. No. 091017,519 filed on Feb. 2, 1998 now U.S. 
Pat. No. 6,109,270 application Ser. No. 081795,272 filed on 
Feb. 4, 1997 now abandoned. 
ORIGIN OF THE INVENTION 
The invention described herein was made by employees 
of the United States Government and may be manufactured 
and used by or for the Government for governmental pur- 
poses without payment of any royalties thereon or therefor. 
BACKGROUND OF THE INVENTION 
1. Technical Field of the Invention 
The present invention relates in general to the field of 
sensors and instruments, and it particularly relates to medi- 
cal diagnostic, prognostic, treatment and surgical instru- 
ments. This invention further relates to a system which 
heuristically provides tissue identification in neuroendos- 
copy and minimally invasive brain surgery. 
2. Description of the Prior Art 
Existing medical instruments provide general diagnoses 
for the detection of tissue interface such as normal tissue, 
cancer tumor, etc. However, such detection has been limited 
clinically to tactile feedback, temperature monitoring, and 
the use of a miniature ultrasound probe for tissue differen- 
tiation during surgical operations. Stereotactic computed 
tomography (CT) scanners, magnetic resonance imaging 
(MRI) devices, and similar other instruments provide guided 
brain biopsy and preoperative scans for use. in neurosurgical 
surgeries. These scans allow samples of brain tissue to be 
obtained with some degree of accuracy. 
However, existing devices provide diagnostic data of 
limited use, particularly in neurosurgery, where the needle 
used in the standard stereotactic CT or MRI guided brain 
biopsy provides no information about the tissue being 
sampled. The tissue sampled depends entirely upon the 
accuracy with which the localization provided by the pre- 
operative CT or MRI scan is translated to the intracranial 
biopsy site. Any movement of the brain or the localization 
device (e.g., either a frame placed on the patient’s head, or 
fiducialsianatomical landmarks which are in turn related to 
the preoperative scan) results in an error in biopsy localiza- 
tion. Also, no information about the tissue being traversed 
by the needle (e.g., a blood vessel) is provided. Hemorrhage 
due to the biopsy needle severing a blood vessel within the 
brain is the most devastating complication of stereotactic CT 
or MRI guided brain biopsy. 
Several other drawbacks are associated with existing 
devices in stereotactic CT or MRI guided brain biopsy. For 
instance, this procedure is labor intensive and requires the 
transfer of localization coordinates from the preoperative 
scan to the localization device. The depth to which the 
needle is passed within the brain is also subject to human 
error. No real-time information is gained about either the 
tissue being biopsied or the tissue being traversed en route 
to the biopsy site. The biopsy information is not provided on 
a real-time basis, and may take a day or more for various 
staining procedures to be performed by the neuropathologist 
on the sampled tissue. The non-simultaneity of the sampling, 
analysis and use precludes existing stereotactic CT and MRI 
guided brain biopsy from being performed remotely, such as 
in space missions, long term space exploration travels, or 
hospitals that are not staffed with a neurosurgeon. 
2 
CT and MRI scans allow neurosurgeons to identify ana- 
tomical regions of the brain with an accuracy on the order of 
one or two millimeters. As presented later, these scans are 
not adequate for the precise localization needed by neuro- 
s surgeons to perform optimally safe surgery. 
CT and MRI scans are obtained pre-operatively. In a 
conventional stereotactic CT or MRI guided brain biopsy, a 
frame is applied to the patient’s head and the scan obtained. 
The coordinates of the desired targets on the scan are then 
10 translated to corresponding coordinates of the frame. The 
patient then undergoes the biopsy through a small hole 
drilled in the skull (three or four millimeters in diameter) 
using a plastic or metal biopsy “needle” that most commonly 
aspirates a very small core of tissue (on the order of one or 
15 two millimeters in diameter by three or four millimeters in 
length). Any movement of the brain, such as can be due to 
changing the position of the patient from the position in 
which the scan was obtained, can introduce error into the 
biopsy coordinates. 
A much greater practical problem arises when the pre- 
operative scan is used to guide the removal of a tumor deep 
within the brain. As the tumor is removed, or the brain 
retracted to permit access to the tumor, the coordinates from 
the pre-operative scans become somewhat invalid. This 
2s error is especially troublesome with recently developed 
systems that use an optically-encoded “arm” in an electro- 
optical camera system for localization during neurosurgical 
operations. 
Another significant problem with using CT and MRI 
30 scans for localization is that they do not provide functional 
localization. As neurosurgical procedures become more 
precise, the need increases for knowledge of the functional 
organization of the brain. The localization necessary to 
perform pallidotomy procedures for Parkinson’s disease is 
3s one example where anatomical localization based on CT or 
MRI scanning is inadequate for optimal treatment, since 
electrophysiological mapping intraoperatively is important 
to maximize the benefit of the operation for a given patient. 
There have been a few recent advances in preoperative 
scanning that provide some information about the functional 
organization of the brain. Functional MRI and PET (Positron 
Emission Tomography) are two examples of such recent 
scanning techniques. However, these scanning techniques 
4s are hampered either by their limited range of functions 
which can be utilized (e.g., functional MRI) or their rela- 
tively poor resolution, for example on the order of one half 
to one centimeter (e.g., PET). 
2o 
4o 
SUMMARY OF THE INVENTION 
It is an object of the present invention to enable the 
placement of multiple neurosurgical sensors and/or effectors 
(or tools), such as a biopsy probe in any desired region of the 
brain with extreme accuracy. 
Another object of the present invention is to enable the 
localization of the neurosurgical sensors and/or effectors 
based on the characteristics of the local brain environment, 
taking into consideration the anatomical and functional 
variability among human (and non-human) brains. 
Still another object of the present invention is to perform 
minimally invasive surgery, for example the localized place- 
ment of the effector and treatment with minimal disruption 
of normal brain functions. An important method for mini- 
mizing invasiveness is miniaturization. 
Yet another object of the present invention is the auto- 
mation of part of surgical procedures. This objective is 
realized by incorporating two disciplines. The first discipline 
so 
ss 
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is robotics and remote control, and the second discipline is 
neural net (or artificial intelligence) learning. Remote con- 
trol has been used by NASA scientists in missions either too 
dangerous or impossible for human performance, such as 
sending an unmanned submarine beneath the Antarctic ice 
cap and a robotic rover into an Alaskan volcano crater. 
Neural net learning allows a computer to gather information 
from repeated exposures to normal and abnormal brain 
tissue which can then be applied to a novel situation, in order 
to decide the type of tissue being encountered. 
A further object of the present invention is to provide a 
heuristic robotic system with a multimodality instrument for 
tissue identification. This instrument will replace “dumb” 
metal needles used to perform exploratory surgeries such as 
biopsies. It will also help avoid certain complications asso- 
ciated with the translation of the lesion (e.g., tumor) coor- 
dinates from MRIiCT scans to the actual lesion using the 
inventive multimodality instrument. These complications 
include the inability to obtain tissue which will allow the 
neuropathologist to make a diagnosis, and the risk of sev- 
ering a blood vessel which may result in a hemorrhage 
causing significant neurological injury or possibly death. 
Briefly, the foregoing and other features and advantages 
of the present invention are realized by a robotics system 
with a multimodality heuristic instrument for tissue identi- 
fication. The instrument includes a computer-controlled 
motor driven probe with a multisensory tip, e.g., a group of 
sensors may be selectively incorporated into the probe tip, or 
near the probe tip or as part of the probe. 
In a preferred embodiment, the probe is driven by a 
computer-controlled actuator mechanism to the appropriate 
depth within the brain for obtaining a continuous and real 
time output of resistance or density of the tissue being 
penetrated. This output is received into a neural net learning 
program which is constantly learning not only the differ- 
ences between normal brain tissue and abnormal brain 
tissue, such as tumors, but also the differences between 
various regions of the brain (e.g., gray matter versus white 
matter). 
In another embodiment where robotic insertion is not 
advantageous, the probe can be a hand-held device and/or 
manually driven instead of motor driven. 
The instrument further includes a micro laser-Doppler 
blood flow probe having a diameter of less than approxi- 
mately 1 mm. This probe detects blood vessels before it can 
disrupt them, and it can further catalog the blood flow 
differences between either normal brain tissue, abnormal 
brain tissue, or various regions of the brain such as gray 
matter and white matter (which are known to have a roughly 
fivefold difference in blood flow). A micro ultrasound probe, 
also less than approximately 1 mm in diameter, can aid in 
blood vessel detection and tissue identification. A PO, 
(partial pressure of oxygen) microprobe, less than 1 mm in 
diameter can aid in the detection of hypoxia which is an 
indication of turner malignancy. 
Ion-selective micro electrodes can also be used to monitor 
such important parameters as pH, calcium, sodium, 
potassium, and magnesium. Additionally, optical fluores- 
cence and/or optical absorbance probes with a diameter of 
less than approximately 1 mm can also be used to monitor 
oxygen and carbon dioxide levels and other parameters of 
the signal. The combination of optical reflectance sensors 
and neural net learning to characterize the tissue being 
penetrated by the probe yields a characteristic optical reflec- 
tance signature which is very valuable in distinguishing and 
identifying different tissues, such as blood vessels, tumors, 
grey matter and white matter. 
4 
The present multimodality instrument offers several 
advantages and can be used in various commercial applica- 
tions. For example, the present instrument improves the 
diagnostic accuracy and precision of general surgery, with 
5 near term emphasis on stereotactic brain biopsy. It automates 
tissue identification with emphasis on stereotactic brain 
biopsy to permit remote control of the procedure. It also 
reduces morbidity of stereotactic brain biopsy. The present 
instrument may also be used in conjunction with various 
surgical tools to increase the safety, accuracy and efficiency 
of surgical procedures. For example, the use of the multi- 
modality instrument for monitoring patients with severe 
head injuries would greatly enhance the surgeon’s capabili- 
ties in neurosurgery. 
The present instrument may also be used in conjunction 
with endoscopes for tissue identification in various types of 
surgery, and can be adapted to a hand held device and/or 
manually driven instead of motor driven for procedures 
where the automated robotic aspect is not advantageous. 
The present instrument may be used in a variety of 
applications including but not limited to tumor ablation in 
neurosurgery, general exploratory surgery, prostate cancer 
surgery, breast cancer surgery, spinal surgery automated 
tissue identification for general surgery use (e.g., detecting 
2s the interface between normal tissue, cancer, tumor, or other 
lesion), automated stereotactic biopsy for neurosurgery, con- 
tinuous monitoring for patients at risk for cerebral ischemia 
and/or increased intracranial pressure (e.g., many patients 
with cerebrovascular disease, tumors, or severe head injury), 
30 and other surgical procedures that could be performed in an 
automated/robotic fashion for minimizing trauma to the 
patient because of decreased exposure time in comparison 
with procedures performed manually and/or more inva- 
sivel y. 
BRIEF DESCRIPTION OF THE DRAWINGS 
The above and other features of the present invention and 
the manner of attaining them will become apparent, and the 
invention itself will be best understood, by reference to the 
4o following description and the accompanying drawings, 
wherein: 
FIG. 1 is a perspective schematic view of a robotic system 
configuration incorporating a multimodality instrument 
(shown schematically) according to the present invention; 
FIG. 2 is an enlarged view of the instrument shown in 
FIG. 1; 
FIG. 3 is a greatly enlarged view of a probe-cannula 
assembly comprised of a multimodality probe and a cannula 
for use in the instrument of FIGS. 1 and 2; 
FIG. 4 is a schematic view of a monitor forming part of 
the robotic system of FIG. 1, illustrating an exemplary user 
interface graphics display forming part of a computer sys- 
tem; 
FIGS. 5A and 5B represent a flow chart illustrating the 
FIG. 6 is a flow chart illustrating the learning process of 
the heuristic system of FIG. 1. 
Similar numerals refer to similar elements in the drawing. 
It should be understood that the sizes of the different 
6o components in the drawings are not in exact proportion, and 
are shown for visual clarity and for the purpose of expla- 
nation. 
DETAILED DESCRIPTION OF THE 
PREFERRED EMBODIMENTS 
FIG. 1 illustrates a robotics heuristic system 10 config- 
ured pursuant to the present invention. The system 10 
1s 
2o 
3s 
4s 
so 
55 general use of the robotic system of FIG. 1; and 
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generally includes a stereotactic device 12 mounted on a 
subject’s head 14; a robotics instrument 16; motor controller 
18; and a computer system 20. While the system 10 will be 
The two guide rails 72 serve as a guide mechanism, and 
extend from the base 81 and serve as guides for the probe 
mounting plate 74, for it to translate slidably along a desired 
described in connection with a neurosurgical application, it 
should be clear that the system 10 may be adapted for use in 
direction with minimal or no pitch or roll deviation, The rails 
72 may include markings 73 for providing a visual indica- 5 
various other medical and non medical applications. 
The stereotactic device 12 is mounted on the subject’s 
head 14 and is affixed to the Skull by means of retaining 
screws or pins 21. The stereotactic device 12 further assists 
tion as to the position of the probe 24 relative to the base 81. 
It is conceivable to the two rails 72 with an appro- 
priate guide mechanism for the actuator mechanism 26. In 
another embodiment the guide mechanism allows the actus- 
in locating a target site, for a brain 19, by 10 tor mechanism 26 to rotate around one rail 72 and to further 
providing a fixed reference Or coordinate system. translate linearly in one or predetermined direction, 
The stereotactic device 12 is well known in the field and is 
commercially available from Radionics, under the trade for 
name BRWiCRW stereotactic systems. In other applications the motor 28 and the probe 24. The probe 
suitable fixation device, such as a “helmet,, which conforms 15 which the probe mounting plate 74 is allowed to journey 
precisely to the subject’s head 14, and/or a device, such as slidably along the rails 72 for translation along the direction 
tion of the arrow A-A coincides substantially with the CT or MRI scan. 
vertical direction. One or more strain gauges 77 may be The robotic instrument 16 is mounted on the stereotactic 
20 secured to the upper surface and/or lower surface of the device 12, and enables one or more sensors and/or one or 
more tools to be handled in a precisely controlled fashion. In probe mounting 74 to pressure Or another 
parameter acting on the cannula 22 or the probe 24. the present illustration for instance, a cannula 22 (within 
penetrate the subject’s brain with an extremely high degree mounted on the base 81 to limit the amount of travel of the 
assembly 27 also shown in FIG, 3 and formed of the cannula possible to initially limit the probe insertion into the cannula 
The probe mounting plate 74 provides a 
the stereotactic device 12 may be replaced with another mounting plate 74 two adjacent Openings through 
an optical system that can be referenced to the preoperative Of the arrow A-A In One the direc- 
which a probe 24 is lodged) is designed to automatically As a safety feature, an adjustable mechanical stop 85 is 
of precision, In another embodiment, the probe-cannula 2s probe 24 in and through the cannula 22. For example, it is 
22 and the probe 24 can be replaced with a probe-tool 22 22. 
assembly wherein the tool is capable of performing various Subsequently, the mechanical stop 85 can be adjusted to 
but not exceeding the tip Of the 
mechanical functions and medical treatment. allow the probe to extend beyond the cannula tip to another 
nism 26 capable of driving the sensors and/or tools with for 
minimal damage to the brain tissue. In the present illustra- securely holding the cannula 22. The cannula mounting Plate 
tion the actuator mechanism 26 includes two stepper motors 76 includes an opening 83 through which the cannula 22 is 
28, 30 that automatica~~y drive the probe 24 inside the inserted for translation in the direction of the arrow B-B. 
cannula 22, and that further drive the probe-cannula assem- 3s In this exemplary illustration the direction of the arrow 
bly 27 into the brain tissue. B-B coincides with that of the arrow A-A, though it is 
The actuator mechanism 26 is controlled by the motor conceivable to design the system 10 such that the probe 24 
controller 18 and the computer system 20, The computer and the cannula 22 translate along two different directions, 
system 20 further includes a neural network program 40 at least before they mate. 
(comprised of a combination of neural networks) used to The cannula mounting Plate 76 Serves as a retention guide 
adaptively learn the information derived by the instrument to the cannula 22 and is adjustably moveable relative to the 
16, for instance resistance and image features of normal base 81 along the direction of the arrow B-B. One Or more 
brain tissue during the surgery. Fast learning neural net- strain gauges 84 may be secured to the upper surface and/or 
works are used to provide near real-time modeling, and a 45 lower surface of the cannula mounting Plate 76 to measure 
fuzzy logic interface to the neural network program is used Pressure Or another Parameter. 
to incorporate expert medical knowledge in the learning The cannula mounting plate 76 also serves as a safety 
process. Identification of abnormal brain tissue is deter- mechanism for limiting the travel of the probe-cannula 
mined by the detection of change and comparison with assembly 27 beyond a predetermined level inside the brain. 
previously learned models of abnormal brain tissues. Where so To this end, as the cannula mounting plate 76 reaches the 
the automated robotic aspect is not advantageous the drive base 81, or a predetermined distance above the base 81, it 
mechanism may be replaced with a manually-driven mecha- stops the advancement of the cannula 22 inside the brain 
nism or inserted directly by hand. tissue. The distance between the cannula mounting plate 76 
The components of the robotics heuristic system 10 will and the base 81 may be adjusted even when the cannula 
now be described in greater detail in connection with FIGS. 5s mounting Plate 76 has reached a Predetermined Position, by 
2, 3 and 4. Starting with the instrument 16, it is comprised means of an adjustable mechanical stop 86 Provided for 
of a mounting structure 70; two guide rails 72; a probe limiting the travel of the cannula mounting plate 76. 
mounting plate 74; a cannula mounting plate 76; the actuator A position encoder 87 may be mounted on the probe 
mechanism 26; the cannula 22; and the probe 24. mounting plate 74 to provide information on the position of 
The mounting structure 70 generally includes a base 81 60 the probe 24 relative to a reference mark on the base 81, or 
that removably and adjustably mates with the stereotactic relative to markings 88 on a graded ruler 89. Similarly, a 
device 12 and provides a mounting interface for the actuator position encoder 90 may be mounted on the cannula mount- 
mechanism 26. The base 81 may be made of any suitable ing plate 76 to provide information on the position of the 
light weight material, such as aluminum, and may assume cannula 22 relative to the reference mark on the base 81, or 
various shapes that best suit the application for which it is 6s relative to markings 88 on the ruler 89. 
used. The base 81 includes an opening 82 that serves as a The actuator mechanism 26 includes the two motors 28, 
guide for the cannula 22. 30 and their corresponding lead screws 92 and 93, respec- 
The robotic instrument 16 includes an actuator mecha- 30 limit for the purpose Of a probe effector. 
The mounting Plate 76 Provides a 
US 6,718,196 B3 
7 
tively. The motor 30 is a stepper motor as is generally known 
in the field. In this particular illustration the motor 30 is 
available from Air Pax Corporation, in California, as model 
number L 9 2211-P2. The motor 28 is generally similar to 
the motor 30. It should however be clear that another 
suitable drive mechanism may alternatively be used to drive 
the cannula 22 by itself or in combination with the probe 24. 
The motor 30 is fixedly secured to the cannula mounting 
plate 76 via the motor housing, and is further secured to the 
base 81 by means of the lead screw 93. To this effect, one 
end 94 of the lead screw 93 is affixed to the base 81, and the 
opposite end of the lead screw 93 is free. The housing of the 
motor 30 traverses the lead screw 93. As the motor 30 runs, 
it causes its housing to translate linearly in the direction of 
the arrow B-B, thus driving the cannula mounting plate 76 
and the cannula attached thereto. 
The lead screw 92 extends through the housing of the 
motor 28 and the probe mounting plate 74, and operates 
similarly to the lead screw 93. One end 95 of the lead screw 
92 is affixed to the cannula mounting plate 76, the housing 
of the motor 30, or to a guide 96 extending from, and secured 
to the probe mounting plate 74. The opposite end of the lead 
screw 92 is affixed to a top base plate 97. As the motor 28 
runs, the housing of motor 28 traverses the lead screw 92 to 
move linearly in the direction of the arrow A-A, thus 
driving the probe mounting plate 74 and the probe 24 
attached thereto toward the cannula 22. 
The cannula 22 is a hollow tubular member that is known 
in the field. The cannula 22 and the probe 4 are available 
from Chorus, located in Minnesota, as models 2120 and 
Archo PEN. The cannula 22 may include markings that 
provide the surgeon with a visual indication as to the 
insertion progress of the probe-cannula assembly 27 within 
the brain tissue. In another embodiment the cannula 22 may 
be replaced with a suitable guide mechanism or eliminated 
all together. 
The probe 24 is a multimodality probe and is tightly 
secured to the probe mounting plate 74. The probe 24 is 
connected to a power, signal and data cabling 98 that 
electrically and/or optically connects the instrument 16 to 
the motor controller 18 and the computer system 20. The 
cabling 98 is supported mechanically by any suitable sup- 
port means (not shown) to prevent the cabling 90 from 
excessive bending. 
As illustrated in FIG. 3, the probe 24 may include one or 
more of the following sensors andieffectors (or tools) 99, 
although the following or other types of sensors and/or tools 
may alternatively be used depending on the application for 
which they are used: 
Strain gauge for measuring the penetration resistance. For 
example, the strain gauge is available from Entran 
Devices Corporation, located in New Jersey, as model 
number EPIH-lll-lOOP/RTV. 
Wick in needle microprobe for measuring interstitial 
pressure. 
Laser Doppler blood flow sensor for measuring the prox- 
imity of the blood vessels to the cannula tip as well as 
the rate of blood flow. For example, the laser Doppler 
blood flow sensor is available from VASAMEDICS, 
located in Minnesota, as model number BPM’. 
Ultrasound probe for tissue identification. 
Endoscope for providing image data. For example, the 
endoscope is available from Johnson & Johnson 
Professional, Inc., as model number 83-1337. 
PO, (partial pressure of oxygen) microprobe for measur- 
ing hypoxia. 
8 
Laser and/or other optical sensors for measuring the 
Temperature sensor to measure tissue temperature. 
Ion specific sensors to measure the concentration of 
Microelectrode to measure brain electrical activity. 
Tissue ablation laser. 
Effectors such as: biopsy foreceps, malleable biopsy 
foreceps, grasping foreceps, micro-scissors, coagulator, 
irrigator. 
The general use and operation of the system 10 will now 
be described in connection with FIGS. 5A and 5B. The 
surgeon starts by positioning the stereotactatic device 12 on 
is the subject’s head 14. The stereotactic device 12 which is 
then mounted and tightly secured in place (block 101). A C T  
or MRI scan can be obtained with the stereotactic device 12 
in place is used to relate the procedure to a prior CT or MRI 
scan. A hole may be drilled in the subject’s skull at a 
20 predetermined site, either manually or robotically using the 
system 10. 
Having selected the proper sensors and/or tools forming 
part of the probe 24, the surgeon mounts the Instrument 16 
on the stereotactic device 12 (block 103) and calibrates the 
zs instrument 16, by checking the alignment of the probe 24 
relative to the cannula 22 (block 105) and then checking the 
proper functioning of the instrument 16, the motor controller 
18 and the computer system 20 (block 107). 
With the motor 30 in a non-operative mode and the 
30 cannula mounting plate 76 stationed at a predetermined 
marking 88, the surgeon advances the probe 24 toward the 
cannula 22 (block 109) by means of the motor 28, until the 
probe 24 is housed in its proper position within the cannula 
22. At which time the motor 28 is locked in position. In some 
35 embodiments of the system 10 it is desirable to have the tips 
of the probe 24 and the cannula 22 flush with each other, 
while in other embodiments, such as when tools are used, the 
tips of the probe 24 and the cannula 22 are not flush. As an 
example, the tip of the probe 24 may extend beyond the tip 
Once the calibration stage is completed the surgeon starts 
the surgical stage by instructing the computer system 20 to 
advance the probe-cannula assembly 27 into the brain nor- 
mal tissue (block 111) at a predetermined controlled speed. 
45 The advancement of the probe-cannula assembly 27 is 
performed by operating the motor 30, which causes the 
probe mounting plate 74, the motor 28, the cannula mount- 
ing plate 76, and the probe-cannula assembly 27 to be driven 
simultaneously forward in the direction of the arrow C. 
As the probe-cannula assembly 27 is advancing into 
normal tissue the neural network program within the com- 
puter system 20 learns the properties of the normal tissue 
(block 113) for further processing, as will be described later. 
In certain applications it might be desirable to stop the 
ss advancement of the probe-cannula assembly temporarily 
until sufficient data is collected or to provide the neural 
networks of the computer system 20 sufficient time to learn. 
When either the surgeon or the computer system 20 
determines that sufficient data have. been collected, the 
60 actuator mechanism 26 is instructed to advance the probe- 
cannula assembly to a predetermined target site (115), for 
example tumor 19. The computer system 20 continually 
checks to determine whether changes in the tissue properties 
or blood vessels have been detected (block 117). If the 
65 computer system 20 does not detect property changes or 
blood vessels, it instructs the probe-cannula assembly 27 to 
continue its travel toward the target site (block 115). If on the 
reflectance properties of tissues. 
specific ions. 
i o  
40 of the cannula 22. 
SO 
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other hand the computer system 20 detects property changes 
or blood vessels then it instructs the probe-cannula assembly 
27 to stop advancing (block 119). 
Based on the detection result (block 117) the computer 
system 20 notifies the surgeon of the appropriate action to be 
taken. As an example, the computer system 20 determines 
whether it has detected tissue property changes or blood 
vessels (block 121). If the computer system 20 detects the 
proximity of blood vessels then the surgeon takes the 
appropriate corrective measures, such as to stop the surgery 
or to reroute the probe-cannula assembly 27 (block 125). 
These corrective measures will enable the surgeon to avoid 
injury to the blood vessels. 
If however, the computer system 20 detects tissue prop- 
erty changes (block 127), the neural networks compare the 
measured tissue properties and/or measured changes in 
tissue properties to previously learned properties and to 
reference properties (block 129). At this stage the surgeon 
will confidently perform the necessary surgical procedure 
(block 131). 
A few exemplary surgical procedures that can be per- 
formed using the system 10 are: 
Automated tissue identification for general surgery use, 
for detecting the interface between normal tissue, 
cancer, or tumor. For example, surgery to remove 
prostate cancer can be accomplished accurately with 
minimal damage to normal tissue. 
Automated stereotactic biopsy for neurosurgery. 
Continuous monitoring for patients at risk for cerebral 
ischemia and/or increased intracranial pressure. 
With the development of multimodality effectors as well 
as multimodality sensors on the neurosurgical probe, 
many neurosurgical procedures could be performed in 
an automated/robotic fashion, thus minimizing trauma 
to the brain tissue because of the decreased exposure 
needed in comparison to open procedures performed by 
a neurosurgeon manually. Examples include the precise 
placement of (a) electrodes (epilepsy), (b) chemothera- 
peutic agents or radiation seeds (brain tumors), and (c) 
transplanted tissue (movement disorders such as Par- 
kinson’s disease). Increased precision of intraoperative 
localization and excision (or ablation with a laser 
beam) of deep brain lesions would be possible. 
In vivo injection of chemicals and tissue. 
Scientific and animal research. 
In one embodiment of the system 10, once the target site 
has been detected and reached, the sensing probe 24 is 
retracted from the cannula 22 by reversing the operation of 
the motor 28. A substitute probe, for instance a probe 24 
containing tools, can then be positioned inside the cannula 
22 as described above, for aiding in the surgical procedure. 
For neurosurgical biopsy applications, the instrument 16 
is mounted on the stereotactic frame 12 in order to have the 
biopsy probe 24 penetrate the brain in a precisely controlled 
fashion. The resistance of the brain tissue being penetrated 
is monitored by a miniature (e.g., 0.050 inch-diameter) 
circular strain gauge 93 attached to the tip of the biopsy 
probe 24. Other modality sensors such as a miniature 
endoscope or laser Doppler blood flow sensor are mounted 
near the probe tip to provide real-time tissue images and the 
ability to detect the proximity of blood vessels. 
The motor controller 18 drives, and precisely controls the 
motors 28, 30. In a preferred embodiment the motor con- 
troller 18 includes a circuit board that includes control logic 
for generating commands. The motor controller 18 is avail- 
able from Motion Engineering, Inc., located in California, as 
10 
model number PCXIDSP-800. The motor controller 18 
further includes an amplifier that generates the electrical 
current to drive the motors. The amplifier is available from 
Haydon Switch & Instrument, Inc., located in Connecticut, 
5 as part number 39105. Some or all of the motor controller 18 
may be installed internally or externally relative to the 
computer system 20. 
With reference to FIG. 4, the computer system 20 gen- 
erally includes an instrument control unit 150, a central 
processing unit (CPU) 152, a neural network module 154, a 
fuzzy logic interface 156, and a three-dimensional (3D) 
graphics interface 158. 
The instrument control unit 150 controls the various 
sensors and tools and performs signal processing for the 
various sensors and tools of the probe 24. As an example, the 
instrument control unit 150 can change the brightness and 
contrast of images generated by an endoscope; change the 
sensitivity of a laser Doppler; switch laser sources; interpret 
reflectance signals; turns tools ON and OFF, etc. 
The CPU 152 may have any suitable speed, for example 
200 MHZ, for acquiring data, signal processing; controlling 
the graphics display; and providing a user friendly interface. 
The computer system 20 may be connected via a suitable 
communication link 157 to remote computers or other 
25 systems, which, for example enable the remote operation 
and control of the system 10. 
The neural network module 154 is used to adaptively 
learn the information provided by the instrument 16. As an 
example, the neural network module 154 can learn the 
3o characteristics of a particular subject’s normal brain tissue, 
such as resistance, color, size, shape, patterns, reflectance 
and other factors associated with the various types of sensors 
and tools listed herein, while the surgery is being performed. 
Fast learning neural networks are used to provide near 
35 real-time modeling. The fuzzy logic interface 156 is added 
to the neural networks to incorporate expert medical knowl- 
edge in the learning process. 
Neural networks have described in several publications, 
for instance “How Neural Networks Learn from 
4o Experience”, by G. H. Hinton, Scientific American, Sep- 
tember 1992, pages 145-151. However, the combination of 
various neural networks and the fuzzy logic interface 156 to 
automatically conduct important aspects of complicated 
surgical processes telemetrically, interactively with the 
45 surgeon, and with minimal risks to the patients is believed to 
be new. 
The neural network module 154 will now be described in 
greater detail in connection with FIG. 6 which illustrates the 
learning process 200 of the heuristic system 10. The neural 
network module 154 is trained (block 202), In combination 
with the fuzzy logic, to create a model of various types of 
tissues. The training is carried out using. one or a combi- 
nation of suitable hybrid neural networks, including but not 
limited to: 
15 . 
2o 
55 Backpropagation. 
Radial basis function (RBF) 
Infold self organizing feature map. 
Cerebellar model articulation computer (CMAC). 
For near real-time modeling of brain tissue, radial basis 
60 function (RBF), Infold self organizing feature maps and 
cerebellum model arithmetic computer (CMAC) neural net- 
works are used in various combinations to provide fast 
learning and enhanced modeling. Data used for learning 
include (1) instrument sensor data that has been signal 
65 processed to provide a set of parameters which captures the 
main characteristics of the tissue; (2) expert knowledge data 
that has been processed through fuzzy logic to provide a set 
US 6,718,196 B1 
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of parameters to aid in the modeling of the tissue being priate sequence stack of MRI or CT scans. In each view, a 
penetrated; and (3) tissue identification data provided by graphical model of the probe is driven in motion in real-time 
pre-trained neural networks to aid in the classification of the by data incoming from the probe. In addition, the multisen- 
tissue being penetrated. sory outputs from the actual probe are displayed graphically 
pre-trained neural networks are neural networks which 5 in real-time at the probe tip in each view. A closeup of the 
have been trained using reference tissues and which are Probe tip is Provided to show fine details of the MRI Or CT 
continually being updated based on instrument sensor data Scans as the Probe approaches each layer. These views 
obtained from surgery and confirmed tissue type from labo- provide a virtual reality environment for visualizing the 
ratory test results of the biopsied tissue. approach to the target site and the probe proximity to critical 
normal tissue (block 111), the neural network module 154 The 3D graphics interface 158 further includes an i d -  
analyzes the input signals (block 204) from the instrument cator 163 for the robotics system that provides an indication 
16, and learns, on a near real-time basis (block 206), the as to the status and trend analysis of the system 10. The 3D 
specific properties of the normal tissue for the particular graphics interface 158 may also Provide access to Patient 
subject. The neural network module 154 then develops an is records Or data, to remote surgery experts and to various 
envelope or model for the specific properties learned (block databases. 
208). The neural network module 154 has the ability to In another embodiment for diagnosis Or surgery where 
develop a separate envelope for each of the parameters or robotic insertion is not advantageous, the probe as described 
factors being sensed. above can be a hand-held device inserted by hand into the 
on top of the learned model to define the normal range of the While specific embodiments of the Present system were 
specific properties of the normal tissue, and to further illustrated and described in accordance with the present 
identify the range of the properties of abnormal tissue. The invention, modifications and changes of the system 
neural network module 154 then compares the input signals dimensions, use and operation Will become apparent to those 
acquired by the instrument 16 to the envelope and deter- zs skilled in the art, without departing from the scope of the 
mines whether the input signals fall within the envelope invention. 
(block 210). If the input signals fall within the normal tissue 
range defined by the envelope, the neural network module 
identifies the tissue aenetrated as normal tissue (block 212). 
As the probe-cannula assembly 27 advances through i o  arteries. 
The neural network module 154 then places the envelope 20 subject. 
What is claimed is: 
1. A method for characterizing tissue, the method corn- 
Prising: 
/ I  
and the computer system 20 instructs the instrument to keep 30 
advancing the probe-cannula assembly 27 toward the target 
site (block 115). 
As the probe-cannula assembly 27 advances through the 
tissue the neural network module 154 continues learning on 
a near real-time basis and updating the envelope. The 35 
foregoing routine (blocks 204,206,208,210) is repeated for 
each of the envelopes (if more than one envelope have been 
developed) until the neural network module 154 determines 
that the input signals fall outside one or a combination of 
Once such determination is made the neural network 
module 154 compares the input signals to the pre-taught 
training model and classifies the tissue type (block 214). For 
example, identification of abnormal brain tissue is deter- 
mined by detection of change and comparison with previ- 45 
ously learned models of abnormal brain tissues. The com- 
puter system 20 then inquires whether or not to stop the 
advancement of the probe-cannula assembly 27 (block 216). 
If the surgeon determines that further advancement is 
required then the routine of data collection, analysis and SO 
classification (blocks 204, 206,208,210, 214) is continued 
until such time as the surgeon instructs the computer system 
20 to stop the advancement of the probe-cannula assembly 
27 (block 218). In certain applications it might be desirable 
to have the probe-cannula assembly 27 penetrate the abnor- ss 
mal tissue (or tumor) completely and extend beyond it. 
The operation of the multimodality system 10 is con- 
trolled through the user friendly three-dimensional (3D) 
graphics interface 158. Real-time tissue identification infor- 
mation is also displayed graphically. Patient data is pre- 60 
sented in a three dimensional stereographics display 161. 
Acoustic feedback of selected information is provided as an 
aid to the surgeon. Upon detection of the close proximity to 
blood vessels or abnormal brain tissue, the actuator mecha- 
nism 26 immediately stops the probe penetration. The 3D 65 
stereographics display 161 is comprised of three orthogonal 
views of the anatomy, with each view presenting the appro- 
envelopes of normal properties. 40 
penetrating a patient’s body, adjacent to a selected tissue, 
with a probe, contained in a needle and having at least 
first and second sensors incorporated therein that are 
configured to characterize the tissue, where the at least 
first sensor is drawn from the group of sensors con- 
sisting of  
a sensor of elastic resistance of a selected portion of the 
tissue to mechanical deformation of the selected 
tissue portion; 
a wick in needle sensor of interstitial pressure associ- 
ated with the tissue; 
a laser Doppler sensor of blood flow associated with the 
tissue; 
an ultrasonic probe; 
an endoscope; 
a sensor of partial-pressure of oxygen associated with 
the tissue 
an optical sensor for measuring at least one selected 
optical property of the tissue; 
a sensor of a temperature associated with the tissue; 
an ion-specific sensor of at least one ion associated with 
the tissue; 
a microelectrode sensor for measuring at least one 
selected electrical property associated with the tis- 
sue; 
a mechanical effector; and 
a tissue ablation laser; 
and the second sensor is drawn from the group of sensors 
consisting of  
a sensor of partial pressure of CO, associated with the 
a sensor of a material density associated with the tissue; 
a fluorescence sensor for measuring fluorescence asso- 
an absorbance sensor for measuring optical absorbance 
a chemical sensor of at least one chemical associated 
tissue; 
ciated with the tissue; 
associated with the tissue; 
with the tissue; 
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a position sensor for estimating present location of the 
needle within the patient’s body; and 
a velocity sensor for estimating a velocity of the needle 
relative to a selected location associated with the 
patient’s body; 
acquiring sensor signals from the at least first and second 
sensors at a sequence of times as the needle penetrates 
the patient’s body; and 
analyzing the sensor signals acquired by the at least first 
and second sensors using a computer system including 
a neural network processing system that receives and 
adaptively analyzes information from said first and 
second sensors. 
2. The method of claim 1, further comprising comparing 
information associated with at least one signal received from 
at least one of said first and second sensors with correspond- 
ing information that would be received if said tissue were in 
a normal medical state. 
3. The method of claim 1, further comprising comparing 
information associated with at least one signal received from 
at least one of said first and second sensors with correspond- 
ing information that would be received if said tissue were in 
at least one of a tumorous medical state and a cancerous 
medical state. 
4. The method of claim 1, further comprising using said 
ultrasonic sensor to detect at least one of presence and 
absence of blood vessels within said tissue and presence and 
absence of blood vessels adjacent to said tissue. 
5. The method of claim 1, further comprising using said 
ion-specific sensor to measure concentration of at least one 
of hydrogen ions, hydroxyl ions, calcium ions, sodium ions, 
potassium ions and magnesium ions present in said tissue. 
6. The method of claim 1, further comprising selecting 
said tissue to be a selected portion of said patient’s brain. 
7. The method of claim 6, further comprising using said 
probe to detect presence of at least one of cerebral ischemia 
and intercranial pressure in the selected portion of the brain. 
8. The method of claim 1, further comprising providing 
said probe with a capability to detect presence of an interface 
between a first tissue that is normal and a second tissue that 
includes a tumorous or cancerous growth. 
9. The method of claim 1, further comprising using said 
position sensor for estimating a penetration depth of said 
needle into said patient’s body. 
10. The method of claim 1, further comprising using at 
least one of said at least first and second sensors to measure 
blood flow in said tissue and to compare the measured blood 
flow with at least one reference blood flow value that would 
be measured if said tissue were in a normal medical state. 
11. The method of claim 1, further comprising using at 
least one of said at least first and second sensors to measure 
blood flow in said tissue and to compare the measured blood 
flow with at least one reference blood flow value that would 
be measured if said tissue were in at least one of a tumorous 
medical state and a cancerous medical state. 
12. A medical device for identifying a medical condition, 
the device comprising: 
a needle capable of penetrating a patient’s body, contain- 
ing a multimodality probe and positioned adjacent to a 
selected tissue, the probe including at least first and 
second sensors incorporated therein that are configured 
to characterize the tissue, where the at least first sensor 
is drawn from the group of sensors consisting of  
a sensor of elastic resistance of a selected portion of the 
tissue to mechanical deformation of the selected 
tissue portion; 
a wick in needle sensor of interstitial pressure associ- 
ated with the tissue; 
14 
a laser Doppler sensor of blood flow associated with the 
an ultrasonic probe; 
an endoscope; 
a sensor of partial pressure of oxygen associated with 
the tissue; 
an optical sensor for measuring at least one selected 
optical property of the tissue; 
a sensor of a temperature associated with the tissue; 
an ion-specific sensor of at least one ion associated with 
the tissue; 
a microelectrode sensor for measuring at least one 
selected electrical property associated with the tis- 
sue; 
tissue; 
5 
lo 
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a mechanical effector; and 
a tissue ablation laser; 
and the at least second sensor is drawn from the group of 
sensors consisting of  
a sensor of partial pressure of CO, associated with the 
a sensor of a material density associated with the tissue: 
a fluorescence sensor for measuring fluorescence asso- 
ciated with the tissue; 
an absorbance sensor for measuring optical absorbance 
associated with the tissue; 
a chemical sensor of at least one chemical associated 
with the tissue; 
a position sensor for estimating present location of the 
needle within the patient’s body; and 
a velocity sensor for estimating a velocity of the needle 
relative to a selected location associated with the 
patient’s body; 
a computer system, including a neural network processing 
system, programmed to acquire and adaptively analyze 
sensor signals from the at least first and second sensors 
at a sequence of times as the needle penetrates the 
patient’s body and to analyze the sensor signals 
acquired by the at least first and second sensors to 
determine if at least one of a first medical condition and 
a second medical condition is present. 
13. The system of claim 12, wherein said computer 
system is programmed to analyze said sensor signals by 
comparing information associated with at least one signal 
45 received from at least one of said first and second sensors 
with corresponding information that would be received if 
said tissue were in a normal medical state. 
14. The system of claim 12, wherein said computer 
system is programmed to analyze said sensor signals by 
SO comparing information associated with at least one signal 
received from at least one of said first and second sensors 
with corresponding information that would be received if 
said tissue were in at least one of a tumorous medical state 
and a cancerous medical state. 
15. The system of claim 12, wherein said probe uses said 
ultrasonic sensor to detect at least one of presence and 
absence of blood vessels within said tissue and presence and 
absence of blood vessels adjacent to said tissue. 
16. The system of claim 12, wherein said probe uses said 
60 ion-specific sensor to measure concentration of at least one 
of hydrogen ions, hydroxyl ions, calcium ions, sodium ions. 
potassium ions and magnesium ions present in said tissue. 
17. The system of claim 12, wherein said tissue is selected 
to be a selected portion of said patient’s brain. 
18. The system of claim 17, wherein said probe uses said 
probe to detect presence of at least one of cerebral ischemia 
and intercranial pressure in the selected portion of the brain. 
2o 
tissue; 
25 
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19. The system of claim 12, wherein said probe has a flow with at least one reference blood flow value that would 
capability to detect presence of an interface between a first be measured if said tissue were in a normal medical state. 
tissue that is normal and a second tissue that includes a 22. The system of claim 12, wherein at least one of said 
tumorous or cancerous growth. at least first and second sensors has a capability to measure 
20. The system of claim 12, wherein said probe uses said s blood flow in said tissue and to compare the measured blood 
position sensor to estimate a penetration depth of said needle flow with at least one reference blood flow value that would 
into said patient’s body. be measured if said tissue were in at least one of a tumorous 
21. The system of claim 12, wherein at least one of said medical state and a cancerous medical state. 
at least first and second sensors has a capability to measure 
blood flow in said tissue and to compare the measured blood * * * * *  
